You’re At the Center: Learn How the CFIDS Association is Fostering Developing of Safe and Effective Treatments for ME/CFS

The fourth webinar in our spring series focuses on how the Solve ME/CFS Initiative is fostering the development of safe and effective therapies for ME/CFS. Please join us!

Date/Time (Live Event): Wednesday, April 17, 2013 at 1 p.m. EDT
Speakers: Suzanne Vernon, Ph.D. (Scientific Director) and Mark Stone (Director of Development), The Solve ME/CFS Initiative

Dr. Suzanne Vernon and Mark Stone described the Association’s venture philanthropy model of being a convener, connector and collaborator to move promising discoveries through the drug development process, keeping the patient as our central focus every step of the way.


The first three programs in our spring webinar series provide helpful background information for this topic. Recordings are archived on the Association’s SolveCFS YouTube channel:

Learn more about other webinars in the series and our special patient-focused survey. We’ll use all the responses submitted by April 17 in the analysis for the FDA meeting; the survey will stay open indefinitely to continue collecting information from as large a group of stakeholders as possible. Thank you to 1,170+ people who have started or completed the survey so far.

We look forward to your participation!

We make every effort to record our webinar programs and post the recordings on our YouTube channel for those unable to attend the live event and for later reference.

*We use the term ME/CFS to refer to conditions also known as chronic fatigue syndrome, CFS, myalgic encephalomyelitis, myalgic encephalopathy, ME and by other names.